Study Stopped
lack of recruitment
Excision Limits of Oral Cavity Tumor by Narrow Band Imaging
NBI-CAB
2 other identifiers
interventional
23
1 country
1
Brief Summary
This study evaluates the feasibility of the NBI technique in the detection of early cancer lesions.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for phase_2 cancer
Started Jul 2010
Typical duration for phase_2 cancer
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
July 1, 2010
CompletedFirst Submitted
Initial submission to the registry
September 8, 2010
CompletedFirst Posted
Study publicly available on registry
September 9, 2010
CompletedPrimary Completion
Last participant's last visit for primary outcome
March 1, 2012
CompletedStudy Completion
Last participant's last visit for all outcomes
December 31, 2014
CompletedMarch 16, 2026
March 1, 2026
1.7 years
September 8, 2010
March 12, 2026
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Reliability for detection of subclinical lesions
Concordance between the histological data and the lesions detected by the NBI technique
baseline
Secondary Outcomes (2)
Excision limits quality criteria
baseline
Detection of suspect lesions
baseline
Study Arms (1)
Patient with oral cavity cancer
EXPERIMENTALPatient treated by surgery for the oral cavity cancer
Interventions
The suspected lesions will be located before the excision, during the surgery. 1. With traditional light 2. NBI technique The images will be recorded and compared
In case of suspected lesions detected by the NBI technique, this area is biopsied
In case of positive biopsy, the suspected lesions is excised
Eligibility Criteria
You may qualify if:
- Primitive epidermoid cancer of the oral cavity, proved by histology, not treated previously, patient having a surgery
- No previous surgery for this cancer
- Age \> 18 years
- Patient affiliated to health insurance
- Consent signed by the patient
You may not qualify if:
- Metastatic or recurrent disease
- Health care impossibilities for geographic, social, psychic reasons
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Centre Oscar Lambret
Lille, 59020, France
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Sophie EL BEDOUI, MD
Centre Oscar Lambret
Study Design
- Study Type
- interventional
- Phase
- phase 2
- Allocation
- NA
- Masking
- NONE
- Purpose
- DIAGNOSTIC
- Intervention Model
- SINGLE GROUP
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
September 8, 2010
First Posted
September 9, 2010
Study Start
July 1, 2010
Primary Completion
March 1, 2012
Study Completion
December 31, 2014
Last Updated
March 16, 2026
Record last verified: 2026-03